| 1. |  3PBIOVIAN Noáin (Navarra), Spain | CDMO | Commercial | VIEW |
| 2. |  4 Animals AlsterScience GmbH Hamburg, Germany | Biotech | Preclinical | VIEW |
| 3. |  5QBD-Biotech Aydat, France | CRO | Service Provider | VIEW |
| 4. |  A.N.B. Laboratories Bangkok, Thailand | Pharma | Commercial | VIEW |
| 5. |  ACESO (Austere environments Consortium for Enhanced Sepsis Outcomes) Silver Spring, MD, USA | Diagnostics | Phase 2 | VIEW |
| 6. |  ACPS - Applied Clinical Pharmacology Services Wiesbaden, Germany | CRO | Commercial | VIEW |
| 7. |  AGS Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 8. |  ARENSIA Exploratory Medicine Dusseldorf, Germany | CRO | Commercial | VIEW |
| 9. |  Adcock Ingram Midrand, South Africa | Pharma | Commercial | VIEW |
| 10. |  Adragos Pharma Munich, Germany | CDMO | Commercial | VIEW |
| 11. |  Advanced Clinical Deerfield, Illinois, USA | CRO | Commercial | VIEW |
| 12. |  Aegros Macquarie Park, Australia | Biotech | Clinical | VIEW |
| 13. |  Affitech Copenhagen, Denmark (with R&D in Oslo, Norway and San Francisco, USA) | Biotech | Clinical | VIEW |
| 14. |  Agilent Technologies Santa Clara, United States | Diagnostics | Commercial | VIEW |
| 15. |  Agno Pharmaceuticals Bethlehem, Pennsylvania, USA | CDMO | N/A | VIEW |
| 16. |  AiCuris Anti-infective Cures AG Wuppertal, Germany | Biotech | Phase 3 | VIEW |
| 17. |  Aizant Drug Research Solutions Pvt. Ltd. Hyderabad, India | CDMO | Discovery | VIEW |
| 18. |  | CDMO | Commercial | VIEW |
| 19. |  AlgiPharma AS Sandvika, Norway | Biotech | Phase 2 | VIEW |
| 20. |  Alkem Laboratories Mumbai, India | Pharma | Commercial | VIEW |
| 21. |  Allucent Cary, North Carolina, USA | CRO | Commercial | VIEW |
| 22. |  Angal Biotechnologies Ltd. Suzhou, China | Biotech | Preclinical | VIEW |
| 23. |  Angelini Pharma Rome, Italy | Pharma | Phase 3 | VIEW |
| 24. |  Anthea Pharma Private Limited Hyderabad, India | CDMO | Commercial | VIEW |
| 25. |  Anthem Biosciences Bangalore, India | CDMO | Commercial | VIEW |
| 26. |  ApicHope Pharmaceutical Group Co., Ltd. Guangzhou, China | Pharma | Phase 3 | VIEW |
| 27. |  Appili Therapeutics Inc. Halifax, Canada | Biotech | Commercial | VIEW |
| 28. |  Aquinas Companies, LLC (Fannin Innovation Studio) Houston, Texas, USA | Biotech | Phase 2 | VIEW |
| 29. |  Aramis Biotechnologies Quebec City, Canada | Biotech | Phase 1/2 | VIEW |
| 30. |  | CDMO | Commercial | VIEW |
| 31. |  Ark Biosciences Shanghai, China | Biotech | Commercial | VIEW |
| 32. |  Aspen Global Incorporated Grand Bay, Mauritius | Pharma | Commercial | VIEW |
| 33. |  Astellas Pharma Inc. Tokyo, Japan | Pharma | Discovery to Phase 3 | VIEW |
| 34. |  Aurigene Pharmaceutical Services Limited Bengaluru, India | CDMO | Commercial | VIEW |
| 35. |  Aurigon Labs Munich, Germany | CRO | Preclinical | VIEW |
| 36. |  AusperBio San Francisco, USA | Biotech | Phase 2 | VIEW |
| 37. |  Avastus Preclinical Services Cambridge, USA | CRO | Discovery | VIEW |
| 38. |  Avegen Health London, United Kingdom | Digital Health | Commercial | VIEW |
| 39. |  Axbio (Anxuyuan Biotechnology) Shenzhen, China | Diagnostics | Commercial | VIEW |
| 40. |  Axis Clinicals Hyderabad, India | CRO | Commercial | VIEW |
| 41. |  Azurity Pharmaceuticals Woburn, USA | Pharma | Commercial | VIEW |
| 42. |  B.Grimm Pharma Bangkok, Thailand | Pharma | Commercial | VIEW |
| 43. |  | Diagnostics | Commercial | VIEW |
| 44. |  BIKEN Foundation Suita, Japan | Biotech | Commercial | VIEW |
| 45. |  BIOCAD Saint Petersburg, Russia | Biotech | Commercial | VIEW |
| 46. |  BPS Bioscience, Inc. San Diego, California, United States | Biotech | Discovery | VIEW |
| 47. |  Basilea Pharmaceutica Allschwil, Switzerland | Pharma | Phase 3 | VIEW |
| 48. |  Batavia Biosciences Leiden, Netherlands | CDMO | N/A | VIEW |
| 49. |  Bavarian Nordic A/S Hellerup, Denmark | Biotech | Commercial | VIEW |
| 50. |  Beckman Coulter Life Sciences Indianapolis, USA | MedTech | Commercial | VIEW |
| 51. |  Becton Dickinson Franklin Lakes, New Jersey, USA | MedTech | Commercial | VIEW |
| 52. |  Beijing Sungen Biomedical Technology Co., Ltd. Beijing, China | Biotech | Phase 2 | VIEW |
| 53. |  Belupo d.d. Koprivnica, Croatia | Pharma | Commercial | VIEW |
| 54. |  BenevolentAI London, United Kingdom | Biotech | Phase 1|Phase 2|Preclinical | VIEW |
| 55. |  Benitec Biopharma Inc. Hayward, California, USA | Biotech | Phase 1b/2a (BB-301), Preclinical (other programs) | VIEW |
| 56. |  Bexon Clinical Consulting, LLC Upper Montclair, New Jersey, USA | CRO | - | VIEW |
| 57. |  Bharat Biotech Hyderabad, India | Biotech | Commercial | VIEW |
| 58. |  | CDMO | Commercial | VIEW |
| 59. |  Binex Co., Ltd. Busan, South Korea | CDMO | Commercial | VIEW |
| 60. |  Bio Farma Bandung, Indonesia | Pharma | Commercial | VIEW |
| 61. |  Bio-Rad Laboratories, Inc. Hercules, California, USA | Diagnostics | Commercial | VIEW |
| 62. |  BioCARTIS Mechelen, Belgium | Diagnostics | Commercial | VIEW |
| 63. |  BioChain Institute Inc. Newark, California, USA | Biotech | Commercial | VIEW |
| 64. |  BioDuro-Sundia Irvine, USA | CDMO | Commercial | VIEW |
| 65. |  BioMed Valley Discoveries Kansas City, Missouri, USA | Biotech | Clinical (Phase 1-2) | VIEW |
| 66. |  BioNTech SE Mainz, Germany | Biotech | Commercial | VIEW |
| 67. |  Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Beijing, China | Biotech | Phase 2 | VIEW |
| 68. |  Biolab Samut Prakan, Thailand | CDMO | Commercial | VIEW |
| 69. |  Biological E. Limited Hyderabad, India | Biotech | Commercial | VIEW |
| 70. |  BiomeBank Adelaide, Australia | Biotech | Clinical | VIEW |
| 71. |  Bion Healthcare Private Limited Ahmedabad, India | CDMO | Commercial | VIEW |
| 72. |  Blau Farmacêutica S.A. Cotia, Brazil | Pharma | Commercial | VIEW |
| 73. |  Boston Institute of Biotechnology Southborough, USA | CDMO | Commercial | VIEW |
| 74. |  Bruluagsa S.A. de C.V. Atlacomulco, Mexico | Pharma | Commercial | VIEW |
| 75. |  BunyaVax Lelystad, Netherlands | Biotech | Phase 1 | VIEW |
| 76. |  C&R Research Inc. Seoul, South Korea | CRO | N/A | VIEW |
| 77. |  CCS Associates, Inc. San Jose, California, USA | CRO | - | VIEW |
| 78. |  CEA (Commissariat à l'énergie atomique et aux énergies alternatives) Paris and Gif-sur-Yvette, France | Biotech | Discovery | VIEW |
| 79. |  | Biotech | Commercial | VIEW |
| 80. |  CERNO Eeklo (Ghent region), Belgium | CRO | Commercial | VIEW |
| 81. |  CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland | Biotech | Phase 3 | VIEW |
| 82. |  CSPC Pharmaceutical Group Limited Shijiazhuang, China | Pharma | Commercial | VIEW |
| 83. |  Cadence Design Systems San Jose, USA | Digital Health | Commercial | VIEW |
| 84. |  Care Access Boston, Massachusetts | CRO | Commercial | VIEW |
| 85. |  Carelon Research Wilmington, Delaware, USA | CRO | Commercial | VIEW |
| 86. |  Cartel Health Care Private Limited Raipur, India | MedTech | Commercial | VIEW |
| 87. |  CellCarta Montreal, Canada | CRO | N/A | VIEW |
| 88. |  Celltrion Incheon, South Korea | Biotech | Commercial | VIEW |
| 89. |  CenExel Clinical Research Salt Lake City, USA | CRO | Private Equity-Backed | VIEW |
| 90. |  Center for Genetic Engineering and Biotechnology (CIGB) Havana, Cuba | Biotech | Commercial | VIEW |
| 91. |  Centricity Research Columbus, Georgia, USA and Toronto, Canada | CRO | Commercial | VIEW |
| 92. |  Cepheid Sunnyvale, California, USA | Diagnostics | Commercial | VIEW |
| 93. |  Cerebras Systems Sunnyvale, USA | Digital Health | Commercial | VIEW |
| 94. |  Chan Zuckerberg Biohub Network San Francisco, USA | Biotech | Discovery | VIEW |
| 95. |  Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ) Lianyungang/Nanjing, China | Pharma | Commercial | VIEW |
| 96. |  China Meheco Corporation Beijing, China | Pharma | Commercial | VIEW |
| 97. |  Choose Life Biotech SA Bellinzona, Switzerland | Biotech | Preclinical | VIEW |
| 98. |  ChuanXin Biomedicine Suzhou, China | Biotech | Phase 1 | VIEW |
| 99. |  Ciencia Research AB Stockholm, Sweden | CRO | Private Equity-Backed | VIEW |
| 100. |  Citi Pharma Limited Lahore, Pakistan | Pharma | Commercial | VIEW |
| 101. |  ClearB Therapeutics, Inc. Concord, Massachusetts, USA | Biotech | Phase 1 | VIEW |
| 102. |  Cliantha Research Ahmedabad, India | CRO | Commercial | VIEW |
| 103. |  ClinChoice Fort Washington, USA / Shanghai, China | CRO | N/A | VIEW |
| 104. |  Clinical Process Services (CPS) Dubai, United Arab Emirates | CRO | Commercial | VIEW |
| 105. |  CloudCath San Francisco, USA | MedTech | Commercial | VIEW |
| 106. |  Constructor Group Schaffhausen, Switzerland | Biotech | Preclinical | VIEW |
| 107. |  Cosmo Pharmaceuticals N.V. Dublin, Ireland | Pharma | Commercial | VIEW |
| 108. |  Crescent Pharma Basingstoke, United Kingdom | Pharma | Commercial | VIEW |
| 109. |  Curative Biotechnology Inc Boca Raton, Florida, USA | Biotech | Pre-Clinical|IND-Enabling Studies | VIEW |
| 110. |  | Biotech | Phase 2 | VIEW |
| 111. |  Curebase San Francisco, USA | Digital Health | Commercial | VIEW |
| 112. |  | Digital Health | Service Provider | VIEW |
| 113. |  CytoAgents Pittsburgh, USA | Biotech | Phase 2 | VIEW |
| 114. |  Cytocom, Inc. Fort Collins, Colorado, USA | Biotech | Phase 2/Phase 3 | VIEW |
| 115. |  Cytonus Therapeutics Carlsbad, California, United States | Biotech | Phase 1 | VIEW |
| 116. |  Cytorex Biosciences Weston, Florida, USA | Biotech | Preclinical | VIEW |
| 117. |  Cytovance Biologics Oklahoma City, USA | CDMO | Commercial | VIEW |
| 118. |  DP Clinical, Inc. Rockville, Maryland, USA | CRO | - | VIEW |
| 119. |  Daiichi Sankyo Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 120. |  Daito Pharmaceutical Co., Ltd. Toyama City, Japan | CDMO | Commercial | VIEW |
| 121. |  Danaher Corporation Washington, D.C., USA | Biotech | N/A | VIEW |
| 122. |  Demedica San Pedro Sula, Honduras | CRO | Commercial | VIEW |
| 123. |  DevaCell, Inc. San Diego, USA | Biotech | Preclinical | VIEW |
| 124. |  Development Center for Biotechnology (DCB) Taipei, Taiwan | Biotech | Preclinical | VIEW |
| 125. |  Dong-A Socio Holdings Co., Ltd. Seoul, South Korea | Pharma | Commercial | VIEW |
| 126. |  Drugs for Neglected Diseases initiative (DNDi) Geneva, Switzerland | Biotech | Commercial | VIEW |
| 127. |  | CRO | Commercial | VIEW |
| 128. |  EEE Pharma Maharashtra, India | Pharma | Commercial | VIEW |
| 129. |  EPS Corporation Shinjuku-ku, Tokyo, Japan | CRO | N/A | VIEW |
| 130. |  Eczacıbaşı Pharmaceutical and Industrial Investment Co. Istanbul, Turkey | Pharma | Commercial | VIEW |
| 131. |  Edge Therapeutics, Inc. Princeton, New Jersey, USA | Biotech | Phase 3 | VIEW |
| 132. |  EirGenix, Inc. New Taipei City, Taiwan | CDMO | Commercial | VIEW |
| 133. |  Eleven Therapeutics Cambridge, United Kingdom | Biotech | Discovery | VIEW |
| 134. |  Emergent BioSolutions Gaithersburg, Maryland, USA | Biotech | Commercial | VIEW |
| 135. |  Emmes Group Rockville, Maryland, USA | CRO | N/A | VIEW |
| 136. |  Empresa de Laboratorios AICA La Lisa, Havana, Cuba | Pharma | Commercial | VIEW |
| 137. |  Enlivex Therapeutics Ltd. Ness Ziona, Israel | Biotech | Phase 2 | VIEW |
| 138. |  Enzo Biochem, Inc. Farmingdale, New York, USA | Biotech | Discovery | VIEW |
| 139. |  Epic Semi Vancouver, Canada | MedTech | Commercial | VIEW |
| 140. |  Ergomed Guildford, United Kingdom | CRO | Commercial | VIEW |
| 141. |  EuBiologics Co., Ltd. Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 142. |  Eurofarma Itapevi, São Paulo, Brazil | Pharma | Multiple stages (Discovery to Commercial) | VIEW |
| 143. |  Eurofins PHAST GmbH Homburg, Germany | CRO | Commercial | VIEW |
| 144. |  Evonik Industries AG Essen, Germany | CDMO | Commercial | VIEW |
| 145. |  Evopoint Biosciences Suzhou, China | Biotech | Commercial (NDA Stage) | VIEW |
| 146. |  Evotec SE Hamburg, Germany | CDMO | Commercial | VIEW |
| 147. |  Extrovis Baar, Switzerland | CDMO | Commercial | VIEW |
| 148. |  | CRO | Phase 3 | VIEW |
| 149. |  FP Clinical Pharma S.R.L. Buenos Aires, Argentina | CRO | Phase 4 | VIEW |
| 150. |  | Diagnostics | Preclinical | VIEW |
| 151. |  Fareva Luxembourg, Luxembourg | CDMO | N/A | VIEW |
| 152. |  Ferozsons Laboratories Limited Lahore, Pakistan | Pharma | Commercial | VIEW |
| 153. |  Fiocruz (Oswaldo Cruz Foundation) Rio de Janeiro, Brazil | Pharma | Commercial | VIEW |
| 154. |  Fiocruz (Oswaldo Cruz Foundation) Rio de Janeiro, Brazil | Biotech | Commercial | VIEW |
| 155. |  Fishfa Biogenics Rajkot, India | Biotech | Commercial | VIEW |
| 156. |  Florence Healthcare Atlanta, USA | Digital Health | Commercial | VIEW |
| 157. |  | Biotech | Phase 2 | VIEW |
| 158. |  Fortrea Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 159. |  Freyr Solutions Princeton, New Jersey, USA | CRO | Commercial | VIEW |
| 160. |  Frontage Laboratories, Inc. Exton, USA | CRO | Commercial | VIEW |
| 161. |  Fujifilm Diosynth Biotechnologies Morrisville, North Carolina, USA | CDMO | Commercial | VIEW |
| 162. |  Fundação Butantan São Paulo, Brazil | Biotech | Phase 2 | VIEW |
| 163. |  Fusion Antibodies Belfast, Northern Ireland, United Kingdom | CRO | Discovery|Preclinical|Clinical (clients' projects) | VIEW |
| 164. |  G&L Scientific Marlow, United Kingdom | CRO | Commercial | VIEW |
| 165. |  GSK plc London, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 166. |  Galenicap BV Brussels, Belgium | Biotech | Phase 2 | VIEW |
| 167. |  Galpha Laboratories Limited Mumbai, India | Pharma | Commercial | VIEW |
| 168. |  | Biotech | - | VIEW |
| 169. |  Generifar S.A. Managua, Nicaragua | CDMO | Commercial | VIEW |
| 170. |  Genes2Me Private Limited Gurgaon, India | Diagnostics | Commercial | VIEW |
| 171. |  Getz Pharma Karachi, Pakistan | Pharma | Commercial | VIEW |
| 172. |  Global Clinix LLC Miami, Florida, USA | CRO | Commercial | VIEW |
| 173. |  Global Life Sciences Alliance Philadelphia, PA, USA | CRO | Commercial | VIEW |
| 174. |  Golden State Medical Supply (GSMS) Camarillo, California, USA | Pharma | Commercial | VIEW |
| 175. |  Grifols, S.A. Sant Cugat del Vallès (Barcelona), Spain | Pharma | Phase 3 | VIEW |
| 176. |  Grupo Leti Guarenas, Venezuela | Pharma | Commercial | VIEW |
| 177. |  HUN-REN Veterinary Medical Research Institute (VMRI) Budapest, Hungary | Biotech | Discovery | VIEW |
| 178. |  Halozyme Therapeutics San Diego, USA | Biotech | Commercial | VIEW |
| 179. |  Hayya Life Science Jakarta, Indonesia | CRO | Commercial | VIEW |
| 180. |  Highnoon Laboratories Limited Lahore, Pakistan | Pharma | Commercial | VIEW |
| 181. |  Hologic, Inc. Marlborough, Massachusetts, USA | MedTech | Commercial | VIEW |
| 182. |  Hovione Loures, Lisbon, Portugal | CDMO | Phase 2/3 | VIEW |
| 183. |  Humanwell Healthcare Wuhan, China | Pharma | Commercial | VIEW |
| 184. |  Humasis Anyang-si, South Korea | Diagnostics | Commercial | VIEW |
| 185. |  Hyloris Pharmaceuticals SA Liège, Belgium | Pharma | Commercial | VIEW |
| 186. |  HyperMabs Inc. Montreal, Canada | Biotech | Discovery | VIEW |
| 187. |  | CRO | Commercial | VIEW |
| 188. |  IPS Biopharma AG Bern, Switzerland | Biotech | Phase 2 | VIEW |
| 189. |  Illumina, Inc. San Diego, USA | Diagnostics | Commercial | VIEW |
| 190. |  Immorna Biotherapeutics Morrisville, USA | Biotech | Phase 2 | VIEW |
| 191. |  Immunethep Cantanhede, Portugal | Biotech | Preclinical | VIEW |
| 192. |  ImmunityBio, Inc. Culver City, California, USA | Biotech | Commercial | VIEW |
| 193. |  Immunocore Abingdon, United Kingdom | Biotech | Commercial | VIEW |
| 194. |  Immunomic Therapeutics, Inc. Rockville, Maryland, United States | Biotech | Phase 1 - Phase 2 | VIEW |
| 195. |  InClin, Inc. San Mateo, USA | CRO | N/A | VIEW |
| 196. |  Incepta Pharmaceuticals Ltd. Dhaka, Bangladesh | Pharma | Commercial | VIEW |
| 197. |  Incepta Pharmaceuticals Ltd. Dhaka, Bangladesh | Pharma | Commercial | VIEW |
| 198. |  Incepta Vaccine Ltd. Dhaka, Bangladesh | Biotech | Commercial | VIEW |
| 199. |  Inceptua Group Luxembourg, Luxembourg | CRO | N/A | VIEW |
| 200. |  Indian Immunologicals Limited Hyderabad, India | Biotech | Commercial | VIEW |
| 201. |  Inpharma Praia, Cabo Verde | Pharma | Commercial | VIEW |
| 202. |  | CRO | Commercial | VIEW |
| 203. |  Inresa Arzneimittel GmbH Freiburg im Breisgau, Germany | Pharma | Commercial | VIEW |
| 204. |  Institute of Immunology (Imunološki zavod) Zagreb, Croatia | Biotech | Discovery | VIEW |
| 205. |  Instituto Chronos de Apoio à Pesquisa (ICAPE) Brasília, Brazil | CRO | Commercial | VIEW |
| 206. |  Intelligene Taipei, Taiwan | Biotech | Phase 1 | VIEW |
| 207. |  International Centre of Insect Physiology and Ecology (ICIPE) Nairobi, Kenya | Biotech | Discovery|Preclinical|Phase 2 | VIEW |
| 208. |  International Livestock Research Institute (ILRI) Nairobi, Kenya | Biotech | Commercial | VIEW |
| 209. |  JAFRAL d.o.o. Ljubljana, Slovenia | CDMO | N/A | VIEW |
| 210. |  JOINN Laboratories Beijing, China | CRO | Commercial | VIEW |
| 211. |  Japan Institute for Health Security Shinjuku-ku, Tokyo, Japan | Biotech | Discovery | VIEW |
| 212. |  Jeil Pharmaceutical Co., Ltd. Seoul, South Korea | Pharma | Phase 2 | VIEW |
| 213. |  Jiayue Pharmaceutical Guangzhou, China | Biotech | Phase 3 | VIEW |
| 214. |  Jodas Expoim Private Limited Hyderabad, India | Pharma | Commercial | VIEW |
| 215. |  Johnson & Johnson New Brunswick, New Jersey, USA | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 216. |  Junshi Biosciences Shanghai, China | Biotech | Commercial | VIEW |
| 217. |  Juzen Chemical Corporation Toyama, Japan | CDMO | Commercial | VIEW |
| 218. |  KM Biologics Co., Ltd. Kumamoto, Japan | Biotech | Commercial | VIEW |
| 219. |  KSPICO Kuwait City, Kuwait | Pharma | Commercial | VIEW |
| 220. |  Kindstar Global Wuhan, China | Diagnostics | Commercial | VIEW |
| 221. |  KingMylab Guangzhou, China | CRO | N/A | VIEW |
| 222. |  Knight Therapeutics Inc. Montreal, Canada | Pharma | Commercial | VIEW |
| 223. |  Korea Research Institute of Bioscience and Biotechnology Daejeon, South Korea | Biotech | Discovery | VIEW |
| 224. |  Kubost Research Georgia, United States | CRO | - | VIEW |
| 225. |  Labcorp Burlington, North Carolina, USA | Diagnostics | Commercial | VIEW |
| 226. |  Laboratoires Sterop Brussels, Belgium | CDMO | Commercial | VIEW |
| 227. |  Laboratorios Best Mexico City, Mexico | Pharma | Commercial | VIEW |
| 228. |  Laboratorios Liomont, S.A. de C.V. Ciudad de México, Mexico | Pharma | Commercial | VIEW |
| 229. |  Laprophan Casablanca, Morocco | Pharma | Commercial | VIEW |
| 230. |  Lateral Flow Laboratories Cape Town, South Africa | Diagnostics | Commercial | VIEW |
| 231. |  Legend Biotech Somerset, New Jersey, USA | Biotech | Commercial | VIEW |
| 232. |  Legend Biotech Somerset, USA | Biotech | Commercial | VIEW |
| 233. |  Lion TCR Singapore, Singapore | Biotech | Phase 2 | VIEW |
| 234. |  | CDMO | Commercial | VIEW |
| 235. |  Lovelace Biomedical Albuquerque, USA | CRO | Discovery | VIEW |
| 236. |  Lyncmed (Beijing) Biotech Co., Ltd. Beijing, China | Diagnostics | Commercial | VIEW |
| 237. |  MMS Holdings Inc. Canton, USA | CRO | Commercial | VIEW |
| 238. |  MPiriQ Science Technologies GmbH Munich, Germany | Digital Health | Seed | VIEW |
| 239. |  MSD Rahway, New Jersey, USA | Pharma | Commercial | VIEW |
| 240. |  Macrogen Europe Amsterdam, Netherlands | CRO | Commercial | VIEW |
| 241. |  Mark Cuban Cost Plus Drug Company Dallas, USA | Pharma | Commercial | VIEW |
| 242. |  Meclinas Mechelen, Belgium | CRO | Commercial | VIEW |
| 243. |  | CRO | Commercial | VIEW |
| 244. |  Medical & Regulatory Affairs Specialists, LLC Lake Wales, Florida | CRO | Commercial | VIEW |
| 245. |  Meditop Pharmaceutical Ltd. Pilisborosjenő, Hungary | CDMO | Commercial | VIEW |
| 246. |  Medpace Holdings, Inc. Cincinnati, Ohio, United States | CRO | N/A (Service Provider - Not Drug Development) | VIEW |
| 247. |  Meiji Seika Pharma Tokyo, Japan | Pharma | Phase 3 | VIEW |
| 248. |  Menarini Group Florence, Italy | Pharma | Commercial | VIEW |
| 249. |  Merck & Co., Inc. Rahway, New Jersey, United States | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 250. |  MetrioPharm AG Zurich, Switzerland | Biotech | Phase 2 | VIEW |
| 251. |  Metrum Research Group Tariffville, Connecticut, USA | CRO | - | VIEW |
| 252. |  | Biotech | Commercial | VIEW |
| 253. |  Mogam Institute for Biomedical Research Seoul, South Korea | Biotech | Discovery|Preclinical | VIEW |
| 254. |  Mubadala Bio Abu Dhabi, United Arab Emirates | CDMO | Commercial (Manufacturing & Distribution) | VIEW |
| 255. |  NKure Therapeutics Bengaluru, India | Biotech | Preclinical | VIEW |
| 256. |  Nanjing Vazyme Biotech Co., Ltd. Nanjing, China | Biotech | Commercial | VIEW |
| 257. |  Nanogen Pharmaceutical Biotechnology JSC Ho Chi Minh City, Vietnam | Biotech | Commercial | VIEW |
| 258. |  Natco Pharma Limited Hyderabad, India | Pharma | Commercial | VIEW |
| 259. |  National Health Laboratory Service (NHLS) Johannesburg, South Africa | Diagnostics | - | VIEW |
| 260. |  National Resilience, Inc. La Jolla, California, USA | CDMO | Commercial | VIEW |
| 261. |  Nevakar, Inc. Bridgewater, New Jersey, USA | Pharma | Phase 3 | VIEW |
| 262. |  NovaDigm Consulting Group Rockville, Maryland, USA | Biotech | Phase 2 | VIEW |
| 263. |  Novavax, Inc. Gaithersburg, Maryland, USA | Biotech | Commercial + Phase 3 | VIEW |
| 264. |  | CRO | Discovery through Phase IV | VIEW |
| 265. |  Oceanus Plus Beijing, China | Digital Health | Commercial | VIEW |
| 266. |  Ocugen, Inc. Malvern, Pennsylvania, USA | Biotech | Phase 3 | VIEW |
| 267. |  Oncogenexe Biotech Pty Ltd Fourways, South Africa | Biotech | Phase 2 | VIEW |
| 268. |  Ondine Biomedical Inc. Vancouver, Canada | MedTech | Commercial | VIEW |
| 269. |  OraSure Technologies, Inc. Bethlehem, Pennsylvania, USA | Diagnostics | Commercial | VIEW |
| 270. |  Orchid Pharma Ltd Chennai, India | Pharma | Commercial | VIEW |
| 271. |  Osel Inc. Mountain View, USA | Biotech | Phase 3 | VIEW |
| 272. |  Otsuka Pharmaceutical Co., Ltd. Tokyo, Japan | Pharma | Commercial | VIEW |
| 273. |  | CRO | - | VIEW |
| 274. |  PBS Regulatory Consulting Bridgewater, New Jersey, USA | CRO | Commercial | VIEW |
| 275. |  | Pharma | Commercial | VIEW |
| 276. |  PPD (Pharmaceutical Product Development) Wilmington, North Carolina, USA | CRO | Commercial | VIEW |
| 277. |  | CRO | Commercial | VIEW |
| 278. |  PT Etana Biotechnologies Indonesia Jakarta, Indonesia | Biotech | Commercial | VIEW |
| 279. |  PT Meprofarm Bandung, Indonesia | Pharma | Commercial | VIEW |
| 280. |  Panion & BF Biotech Inc. Taipei, Taiwan | Pharma | Commercial | VIEW |
| 281. |  Parexel Raleigh, North Carolina, USA | CRO | Phase I-IV (as a CRO, Parexel manages client pipelines, not its own) | VIEW |
| 282. |  Pasteur Institute in Ho Chi Minh City Ho Chi Minh City, Vietnam | Biotech | Phase 2 | VIEW |
| 283. |  Pasteur Institute of Iran Tehran, Iran | Biotech | Discovery | VIEW |
| 284. |  PharmaEssentia Taipei, Taiwan | Biotech | Commercial | VIEW |
| 285. |  PharmaLex (now Cencora PharmaLex) Multiple global headquarters; main offices in Switzerland and US | CRO | Consulting/Support across all stages - Discovery through Phase 4 | VIEW |
| 286. |  Pharmaprom Casablanca, Morocco | Pharma | Commercial | VIEW |
| 287. |  | CRO | Commercial | VIEW |
| 288. |  Pharmascience Inc. Montreal, Canada | Pharma | Commercial | VIEW |
| 289. |  Pherecydes Pharma SA Romainville, France | Biotech | Phase 2 | VIEW |
| 290. |  Pictura Bio Oxford, United Kingdom | Diagnostics | Preclinical | VIEW |
| 291. |  Polaris Strategic Partners, Inc. United States | CRO | - | VIEW |
| 292. |  Porton Biopharma Limited Salisbury, United Kingdom | CDMO | Commercial | VIEW |
| 293. |  Precigen Germantown, Maryland, USA | Biotech | Commercial | VIEW |
| 294. |  Promega Corporation Madison, USA | Biotech | Discovery | VIEW |
| 295. |  Pure Pharmaceutical Manufacturing L.L.C Abu Dhabi, United Arab Emirates | Pharma | Commercial | VIEW |
| 296. |  Pyramid Laboratories, Inc. Costa Mesa, USA | CDMO | Commercial | VIEW |
| 297. |  QIAGEN N.V. Venlo, Netherlands | Diagnostics | Commercial | VIEW |
| 298. |  Quanterix Corporation Billerica, Massachusetts, USA | Diagnostics | Commercial | VIEW |
| 299. |  Quest Diagnostics Secaucus, New Jersey, USA | Diagnostics | Commercial | VIEW |
| 300. |  R&D Pharma (ООО «ЭР ЭНД ДИ ФАРМА») Moscow, Russia | CRO | Commercial | VIEW |
| 301. |  RDS (Rhythm Diagnostic Systems) Strasbourg, France | Digital Health | Commercial | VIEW |
| 302. |  | Biotech | Phase 1 | VIEW |
| 303. |  Randox Laboratories Crumlin, United Kingdom | Diagnostics | Commercial | VIEW |
| 304. |  Rasan Pharmaceutical Industries Sulaymaniyah, Iraq | Pharma | Commercial | VIEW |
| 305. |  | CRO | Commercial | VIEW |
| 306. |  RemediumOne Colombo, Sri Lanka | CRO | - | VIEW |
| 307. |  Remedy & Company Corporation Tokyo, Japan | CRO | Discovery | VIEW |
| 308. |  | Diagnostics | Commercial | VIEW |
| 309. |  Reyon Pharmaceutical Co., Ltd. Seoul, South Korea | Pharma | Phase 2 | VIEW |
| 310. |  Rho Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 311. |  | Pharma | Commercial | VIEW |
| 312. |  Robert Bosch GmbH Gerlingen, Germany | MedTech | Commercial | VIEW |
| 313. |  | Pharma | Commercial | VIEW |
| 314. |  | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 315. |  Roche Holding AG (via businesspartner.roche.com portal) Basel, Switzerland | Pharma | Phase 1 through Commercial | VIEW |
| 316. |  Ronak Pharmaceutical Co. Tehran, Iran | Pharma | Commercial | VIEW |
| 317. |  SCG Cell Therapy Singapore, Singapore | Biotech | Phase 1/2 | VIEW |
| 318. |  | CRO | Commercial | VIEW |
| 319. |  SISCAPA Assay Technologies, Inc. Washington, DC, USA | Diagnostics | Commercial | VIEW |
| 320. |  SLS Bio Co., Ltd. Suwon, South Korea | CRO | Commercial | VIEW |
| 321. |  SNIPR Biome Copenhagen, Denmark | Biotech | Phase 1b-2a | VIEW |
| 322. |  ST Pharm Co., Ltd. Siheung, South Korea | CDMO | Phase 1 | VIEW |
| 323. |  SV ChemBioTech Inc. Edmonton, Canada | CRO | Preclinical | VIEW |
| 324. |  Saama Technologies Campbell, USA | Digital Health | Commercial | VIEW |
| 325. |  Saint Novel Biotech Limited Hong Kong, China | Digital Health | Discovery | VIEW |
| 326. |  Sance Laboratories Pvt. Ltd. Kottayam, India | Pharma | Commercial | VIEW |
| 327. |  | Pharma | Preclinical through Phase 3 | VIEW |
| 328. |  Sansure Biotech Inc. Changsha, China | Diagnostics | Commercial | VIEW |
| 329. |  Scantox Group Lille Skensved, Denmark | CRO | Discovery | VIEW |
| 330. |  | Diagnostics | Commercial | VIEW |
| 331. |  Selvita S.A. Krakow, Poland | CRO | Discovery | VIEW |
| 332. |  SeqOne Genomics Montpellier, France | Digital Health | Commercial | VIEW |
| 333. |  Shanghai Institute of Materia Medica (SIMM) Shanghai, China | Biotech | Discovery | VIEW |
| 334. |  Shenzhen Salubris Pharmaceuticals Co., Ltd. Shenzhen, China | Pharma | Clinical | VIEW |
| 335. |  Shimadzu Corporation Kyoto, Japan | MedTech | N/A | VIEW |
| 336. |  Shin Poong Pharmaceutical Co., Ltd. Seoul, South Korea | Pharma | Commercial | VIEW |
| 337. |  Shionogi & Co., Ltd. Osaka, Japan | Pharma | Commercial | VIEW |
| 338. |  Shionogi & Co., Ltd. Osaka, Japan | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 339. |  Shionogi B.V. (Shionogi Europe) Amsterdam, Netherlands | Pharma | Commercial | VIEW |
| 340. |  SiFlow (Suzhou) Biotechnology Suzhou, China | MedTech | Commercial | VIEW |
| 341. |  Simtra BioPharma Solutions Bloomington, Indiana, USA | CDMO | Commercial | VIEW |
| 342. |  SinSa Labs Lidingö, Sweden | Biotech | Preclinical | VIEW |
| 343. |  | Pharma | Commercial | VIEW |
| 344. |  Sopan Pharmaceuticals Limited Kathmandu, Nepal | Pharma | Commercial | VIEW |
| 345. |  Sothema Bouskoura, Morocco | CDMO | Commercial | VIEW |
| 346. |  St. Jude Children's Research Hospital Memphis, USA | Biotech | Clinical | VIEW |
| 347. |  Summit Therapeutics Boston, USA | Biotech | Phase 3 | VIEW |
| 348. |  Swiss Tropical and Public Health Institute (Swiss TPH) Allschwil, Switzerland | CRO | Discovery | VIEW |
| 349. |  Synexa Life Sciences Leiden, Netherlands | CRO | Commercial | VIEW |
| 350. |  Syngene International Bengaluru, India | CRO | Commercial | VIEW |
| 351. |  TCG Lifesciences Pvt Ltd Kolkata, India | CRO | Discovery | VIEW |
| 352. |  THINQ Pharma-CRO Ltd Thane, India | CRO | Commercial | VIEW |
| 353. |  TechnoPhage Lisbon, Portugal | Biotech | Phase 1/IIa through Phase 3 in development | VIEW |
| 354. |  Technology Resources, Inc. West Chester, Pennsylvania, USA | CRO | Commercial | VIEW |
| 355. |  TenNor Therapeutics Suzhou, China | Biotech | Phase 3 | VIEW |
| 356. |  Thermo Fisher Scientific Waltham, Massachusetts, United States | CRO | Full spectrum - from drug discovery through Phase I-III and commercial | VIEW |
| 357. |  | CRO | Commercial | VIEW |
| 358. |  Tillotts Pharma AG Rheinfelden, Switzerland | Pharma | Commercial | VIEW |
| 359. |  Tokushukai Clinical Trial Management Center (CTMC) Fujisawa, Japan | CRO | Commercial | VIEW |
| 360. |  Tongze Hexin (Beijing) Medical Technology Co., Ltd. Beijing, China | CRO | - | VIEW |
| 361. |  Tonix Pharmaceuticals Holding Corp. Chatham, New Jersey, USA | Biotech | Commercial | VIEW |
| 362. |  Translational Health Science and Technology Institute (THSTI) Faridabad, India | Biotech | Discovery | VIEW |
| 363. |  TrueBlue Clinical Research Tampa, USA | CRO | Commercial | VIEW |
| 364. |  Tyonex Nigeria Limited Lagos, Nigeria | Pharma | Commercial | VIEW |
| 365. |  Unichem Laboratories Limited Mumbai, India | Pharma | Commercial | VIEW |
| 366. |  Unilab, Inc. Mandaluyong, Philippines | Pharma | Commercial | VIEW |
| 367. |  Unison Pharmaceuticals Private Limited Ahmedabad, India | CDMO | Commercial | VIEW |
| 368. |  United BioPharma Hukou, Taiwan | Biotech | Phase 2/3 | VIEW |
| 369. |  Vaccine Industrial Company (VIC) Riyadh, Saudi Arabia | Biotech | Discovery | VIEW |
| 370. |  Vaxcyte San Carlos, California, USA | Biotech | Clinical (Phase 2 and Phase 3) | VIEW |
| 371. |  Vaxxas Brisbane, Australia | Biotech | Phase 1 | VIEW |
| 372. |  Veristat, LLC Southborough, Massachusetts, USA | CRO | N/A | VIEW |
| 373. |  Viatris Canonsburg, Pennsylvania, United States | Pharma | Phase 1 to Commercial | VIEW |
| 374. |  Vilo Research Group, Inc. Houston, United States | CRO | Commercial | VIEW |
| 375. |  | Biotech | Phase 3 | VIEW |
| 376. |  Vocense Inc. San Antonio, USA | MedTech | Discovery | VIEW |
| 377. |  WEP Clinical Morrisville, USA | CRO | Commercial | VIEW |
| 378. |  Wits Health Consortium (Pty) Ltd Johannesburg, South Africa | CRO | Discovery | VIEW |
| 379. |  Worcester HIV Vaccine Worcester, Massachusetts, USA | Biotech | Phase 2 | VIEW |
| 380. |  WuXi AppTec Shanghai, China | CRO | Commercial | VIEW |
| 381. |  Yangshengtang Co., Ltd. Hangzhou, China | Biotech | Commercial | VIEW |
| 382. |  Yangtze River Pharmaceutical Group (YRPG) Taizhou, China | Pharma | Commercial | VIEW |
| 383. |  Yither Biotech (Shanghai) Co., Ltd. Shanghai, China | Biotech | Phase 1-2 | VIEW |
| 384. |  ZENOAQ (Nippon Zenyaku Kogyo Co., Ltd.) Koriyama, Japan | Biotech | Clinical | VIEW |
| 385. |  Zai Lab Shanghai, China and Cambridge, MA, USA | Biotech | Commercial | VIEW |
| 386. |  Zenagem Philadelphia, Pennsylvania | Biotech | Discovery | VIEW |
| 387. |  Ziphius Vaccines Ghent, Belgium | Biotech | Preclinical | VIEW |
| 388. |  Zybio Inc. Chongqing, China | Diagnostics | Commercial | VIEW |
| 389. |  Zydus Lifesciences Limited Ahmedabad, India | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 390. |  elderbrook solutions GmbH Biberach an der Riss, Germany | CRO | - | VIEW |
| 391. |  hVIVO plc London, United Kingdom | CRO | Phase 2 | VIEW |
| 392. |  | CRO | Phase 3 | VIEW |
| 393. |  | Digital Health | Commercial | VIEW |
| 394. |  tranScrip Wokingham, United Kingdom | CRO | - | VIEW |